CYSTOGRAFIN Drug Patent Profile
✉ Email this page to a colleague
When do Cystografin patents expire, and when can generic versions of Cystografin launch?
Cystografin is a drug marketed by Bracco and is included in one NDA.
The generic ingredient in CYSTOGRAFIN is diatrizoate meglumine. There are eleven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the diatrizoate meglumine profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CYSTOGRAFIN?
- What are the global sales for CYSTOGRAFIN?
- What is Average Wholesale Price for CYSTOGRAFIN?
Summary for CYSTOGRAFIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 32 |
Patent Applications: | 890 |
Drug Prices: | Drug price information for CYSTOGRAFIN |
What excipients (inactive ingredients) are in CYSTOGRAFIN? | CYSTOGRAFIN excipients list |
DailyMed Link: | CYSTOGRAFIN at DailyMed |
Pharmacology for CYSTOGRAFIN
Drug Class | Radiographic Contrast Agent |
Mechanism of Action | X-Ray Contrast Activity |
US Patents and Regulatory Information for CYSTOGRAFIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bracco | CYSTOGRAFIN | diatrizoate meglumine | SOLUTION;URETHRAL | 010040-018 | Approved Prior to Jan 1, 1982 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Bracco | CYSTOGRAFIN DILUTE | diatrizoate meglumine | SOLUTION;URETHRAL | 010040-022 | Nov 9, 1982 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |